Bionano Genomics Stock Options
| BNGO Stock | USD 3.43 0.03 0.88% |
Bionano Genomics' latest option contracts expiring on August 15th 2025 are carrying combined implied volatility of 3.24 with a put-to-call open interest ratio of 0.0 over 10 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on August 15th 2025.
Open Interest Against August 15th 2025 Option Contracts
2025-08-15
The chart above shows Bionano Genomics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Bionano Genomics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Bionano Genomics' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Bionano Genomics
Analyzing Bionano Genomics' in-the-money options over time can help investors to take a profitable long position in Bionano Genomics regardless of its overall volatility. This is especially true when Bionano Genomics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Bionano Genomics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Bionano Genomics' stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Bionano Genomics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Bionano Genomics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Bionano Genomics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Bionano Stock moves the wrong way.
Bionano Current Options Market Mood
Bionano Genomics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Bionano Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Bionano Genomics' options investors are not very successful. Bionano Genomics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Bionano contract
Base on the Rule 16, the options market is currently suggesting that Bionano Genomics will have an average daily up or down price movement of about 0.2% per day over the life of the 2025-08-15 option contract. With Bionano Genomics trading at USD 3.43, that is roughly USD 0.006946. If you think that the market is fully incorporating Bionano Genomics' daily price movement you should consider buying Bionano Genomics options at the current volatility level of 3.24%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Bionano Genomics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Bionano calls. Remember, the seller must deliver Bionano Genomics stock to the call owner when a call is exercised.
Bionano Genomics Option Chain
When Bionano Genomics' strike price is surpassing the current stock price, the option contract against Bionano Genomics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Bionano Genomics' option chain is a display of a range of information that helps investors for ways to trade options on Bionano. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Bionano. It also shows strike prices and maturity days for a Bionano Genomics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | BNGO250815C00003000 | 156 | 3.0 | 0.0 - 0.05 | 0.05 | In |
Call | BNGO250815C00002000 | 210 | 2.0 | 0.0 - 0.05 | 0.05 | In |
Call | BNGO250815C00001500 | 81 | 1.5 | 0.0 - 0.05 | 0.05 | In |
Call | BNGO250815C00001000 | 1282 | 1.0 | 0.0 - 0.05 | 0.05 | In |
Call | BNGO250815C00000500 | 5665 | 0.5 | 0.0 - 0.05 | 0.05 | In |
Put | BNGO250815P00003000 | 1 | 3.0 | 2.5 - 3.0 | 2.5 | Out |
Put | BNGO250815P00002000 | 0 | 2.0 | 1.65 - 2.0 | 1.65 | |
Put | BNGO250815P00001500 | 0 | 1.5 | 1.15 - 1.5 | 1.15 | |
Put | BNGO250815P00001000 | 0 | 1.0 | 0.65 - 1.0 | 0.65 | |
Put | BNGO250815P00000500 | 0 | 0.5 | 0.15 - 0.5 | 0.15 |
Bionano Total Stockholder Equity
Total Stockholder Equity |
|
Bionano Genomics Corporate Management
| Jonathan JD | General Secretary | Profile | |
| Donna Polizio | Global Access | Profile | |
| Klint Rose | Head Development | Profile | |
| Helene Klein | Chief Officer | Profile | |
| Sheila MBA | Vice Marketing | Profile | |
| Christopher Stewart | Chief Officer | Profile | |
| Jonathan Dixon | Global Legal | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionano Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionano Genomics. If investors know Bionano will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionano Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (53.53) | Revenue Per Share | Quarterly Revenue Growth (0.26) | Return On Assets | Return On Equity |
The market value of Bionano Genomics is measured differently than its book value, which is the value of Bionano that is recorded on the company's balance sheet. Investors also form their own opinion of Bionano Genomics' value that differs from its market value or its book value, called intrinsic value, which is Bionano Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionano Genomics' market value can be influenced by many factors that don't directly affect Bionano Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionano Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionano Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionano Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.